Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N.

Science. 1985 Dec 20;230(4732):1350-4.

PMID:
2999980
2.

Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.

Charache S.

Semin Hematol. 1997 Jul;34(3 Suppl 3):15-21. Review.

PMID:
9317197
3.

Management of painful vaso-occlusive crisis of sickle-cell anemia: consensus opinion.

Mousa SA, Al Momen A, Al Sayegh F, Al Jaouni S, Nasrullah Z, Al Saeed H, Alabdullatif A, Al Sayegh M, Al Zahrani H, Hegazi M, Al Mohamadi A, Alsulaiman A, Omer A, Al Kindi S, Tarawa A, Al Othman F, Qari M.

Clin Appl Thromb Hemost. 2010 Aug;16(4):365-76. doi: 10.1177/1076029609352661. Epub 2010 Jun 7. Review.

PMID:
20530056
4.

Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, Beard C, Brambrink T, Wu LC, Townes TM, Jaenisch R.

Science. 2007 Dec 21;318(5858):1920-3. Epub 2007 Dec 6.

5.
6.

In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.

Sebastiano V, Maeder ML, Angstman JF, Haddad B, Khayter C, Yeo DT, Goodwin MJ, Hawkins JS, Ramirez CL, Batista LF, Artandi SE, Wernig M, Joung JK.

Stem Cells. 2011 Nov;29(11):1717-26. doi: 10.1002/stem.718.

7.

Fetal hemoglobin in sickle cell anemia.

Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DH, Steinberg MH.

Blood. 2011 Jul 7;118(1):19-27. doi: 10.1182/blood-2011-03-325258. Epub 2011 Apr 13. Review.

8.

Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia.

DeBaun MR, Armstrong FD, McKinstry RC, Ware RE, Vichinsky E, Kirkham FJ.

Blood. 2012 May 17;119(20):4587-96. doi: 10.1182/blood-2011-02-272682. Epub 2012 Feb 21. Review.

9.

Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia.

Eridani S, Mosca A.

J Blood Med. 2011;2:23-30. doi: 10.2147/JBM.S14942. Epub 2011 Feb 28.

10.

Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia.

Lucarelli G, Isgrò A, Sodani P, Gaziev J.

Cold Spring Harb Perspect Med. 2012 May;2(5):a011825. doi: 10.1101/cshperspect.a011825. Review.

11.

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up.

Am J Hematol. 2010 Jun;85(6):403-8. doi: 10.1002/ajh.21699.

12.

Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.

Connes P, Machado R, Hue O, Reid H.

Clin Hemorheol Microcirc. 2011;49(1-4):151-63. doi: 10.3233/CH-2011-1465. Review.

PMID:
22214686
13.

The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.

Nouraie M, Lee JS, Zhang Y, Kanias T, Zhao X, Xiong Z, Oriss TB, Zeng Q, Kato GJ, Gibbs JS, Hildesheim ME, Sachdev V, Barst RJ, Machado RF, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Rosenzweig EB, Badesch DB, Lanzkron S, Castro OL, Goldsmith JC, Gordeuk VR, Gladwin MT; Walk-PHASST Investigators and Patients.

Haematologica. 2013 Mar;98(3):464-72. doi: 10.3324/haematol.2012.068965. Epub 2012 Sep 14.

14.

Prenatal diagnosis of sickle cell anemia and beta-thalassemia by amniocentesis.

Phillips JA 3rd.

Tex Rep Biol Med. 1980-1981;40:261-72. Review.

PMID:
6275566
15.

Unusual causes of abdominal pain: sickle cell anemia.

Ahmed S, Shahid RK, Russo LA.

Best Pract Res Clin Gastroenterol. 2005 Apr;19(2):297-310. Review.

PMID:
15833695
16.

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial.

Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, et al.

N Engl J Med. 1986 Jun 19;314(25):1593-9.

PMID:
3086721
17.

Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?

McGann PT, Ware RE.

Curr Opin Hematol. 2011 May;18(3):158-65. doi: 10.1097/MOH.0b013e32834521dd. Review.

18.

Bone marrow transplant options and preferences in a sickle cell anemia cohort on chronic transfusions.

Hansbury EN, Schultz WH, Ware RE, Aygun B.

Pediatr Blood Cancer. 2012 Apr;58(4):611-5.

PMID:
22435112
19.

Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia.

Barrett AN, McDonnell TC, Chan KC, Chitty LS.

Clin Chem. 2012 Jun;58(6):1026-32. doi: 10.1373/clinchem.2011.178939. Epub 2012 Mar 26.

20.

Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia.

Alvarez O, Miller ST, Wang WC, Luo Z, McCarville MB, Schwartz GJ, Thompson B, Howard T, Iyer RV, Rana SR, Rogers ZR, Sarnaik SA, Thornburg CD, Ware RE; BABY HUG Investigators.

Pediatr Blood Cancer. 2012 Oct;59(4):668-74. doi: 10.1002/pbc.24100. Epub 2012 Jan 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk